Global Brucellosis Vaccines Market Size, Manufacturers, Opportunities and Forecast to 2030
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
According to APO Research, The global Brucellosis Vaccines market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brucellosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucellosis Vaccines.
The Brucellosis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brucellosis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucellosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brucellosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucellosis Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brucellosis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Brucellosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Brucellosis Vaccines market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brucellosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucellosis Vaccines.
The Brucellosis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brucellosis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Jinyu
- Colorado Serum
- Boehringer Ingelheim
- Biogenesis-Bago
- Vetal Company
- CZ Veterinaria
- SYVA Laboratorios
- Indian Immunologicals
- Qilu
- Tecnovax
- Hester Biosciences
- Zoetis
- Onderstepoort Biological
- Instituto Rosenbusch
- Ceva Sante Animale
- Calier & Biologicos Laverlam
- Biovet
- S19 Vaccine
- RB51 Vaccine Strain
- Cattle
- Sheep
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucellosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brucellosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucellosis Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brucellosis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Brucellosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Brucellosis Vaccines Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Brucellosis Vaccines Sales Estimates and Forecasts (2019-2030)
1.3 Brucellosis Vaccines Market by Type
1.3.1 S19 Vaccine
1.3.2 RB51 Vaccine Strain
1.4 Global Brucellosis Vaccines Market Size by Type
1.4.1 Global Brucellosis Vaccines Market Size Overview by Type (2019-2030)
1.4.2 Global Brucellosis Vaccines Historic Market Size Review by Type (2019-2024)
1.4.3 Global Brucellosis Vaccines Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
1.5.2 Europe Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Brucellosis Vaccines Industry Trends
2.2 Brucellosis Vaccines Industry Drivers
2.3 Brucellosis Vaccines Industry Opportunities and Challenges
2.4 Brucellosis Vaccines Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Brucellosis Vaccines Revenue (2019-2024)
3.2 Global Top Players by Brucellosis Vaccines Sales (2019-2024)
3.3 Global Top Players by Brucellosis Vaccines Price (2019-2024)
3.4 Global Brucellosis Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Brucellosis Vaccines Key Company Manufacturing Sites & Headquarters
3.6 Global Brucellosis Vaccines Company, Product Type & Application
3.7 Global Brucellosis Vaccines Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Brucellosis Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Brucellosis Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Brucellosis Vaccines Tier 1, Tier 2, and Tier
4 BRUCELLOSIS VACCINES REGIONAL STATUS AND OUTLOOK
4.1 Global Brucellosis Vaccines Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Brucellosis Vaccines Historic Market Size by Region
4.2.1 Global Brucellosis Vaccines Sales in Volume by Region (2019-2024)
4.2.2 Global Brucellosis Vaccines Sales in Value by Region (2019-2024)
4.2.3 Global Brucellosis Vaccines Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Brucellosis Vaccines Forecasted Market Size by Region
4.3.1 Global Brucellosis Vaccines Sales in Volume by Region (2025-2030)
4.3.2 Global Brucellosis Vaccines Sales in Value by Region (2025-2030)
4.3.3 Global Brucellosis Vaccines Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 BRUCELLOSIS VACCINES BY APPLICATION
5.1 Brucellosis Vaccines Market by Application
5.1.1 Cattle
5.1.2 Sheep
5.1.3 Others
5.2 Global Brucellosis Vaccines Market Size by Application
5.2.1 Global Brucellosis Vaccines Market Size Overview by Application (2019-2030)
5.2.2 Global Brucellosis Vaccines Historic Market Size Review by Application (2019-2024)
5.2.3 Global Brucellosis Vaccines Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
5.3.2 Europe Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Jinyu
6.1.1 Jinyu Comapny Information
6.1.2 Jinyu Business Overview
6.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jinyu Brucellosis Vaccines Product Portfolio
6.1.5 Jinyu Recent Developments
6.2 Colorado Serum
6.2.1 Colorado Serum Comapny Information
6.2.2 Colorado Serum Business Overview
6.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Colorado Serum Brucellosis Vaccines Product Portfolio
6.2.5 Colorado Serum Recent Developments
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Comapny Information
6.3.2 Boehringer Ingelheim Business Overview
6.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments
6.4 Biogenesis-Bago
6.4.1 Biogenesis-Bago Comapny Information
6.4.2 Biogenesis-Bago Business Overview
6.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biogenesis-Bago Brucellosis Vaccines Product Portfolio
6.4.5 Biogenesis-Bago Recent Developments
6.5 Vetal Company
6.5.1 Vetal Company Comapny Information
6.5.2 Vetal Company Business Overview
6.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vetal Company Brucellosis Vaccines Product Portfolio
6.5.5 Vetal Company Recent Developments
6.6 CZ Veterinaria
6.6.1 CZ Veterinaria Comapny Information
6.6.2 CZ Veterinaria Business Overview
6.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CZ Veterinaria Brucellosis Vaccines Product Portfolio
6.6.5 CZ Veterinaria Recent Developments
6.7 SYVA Laboratorios
6.7.1 SYVA Laboratorios Comapny Information
6.7.2 SYVA Laboratorios Business Overview
6.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 SYVA Laboratorios Brucellosis Vaccines Product Portfolio
6.7.5 SYVA Laboratorios Recent Developments
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Comapny Information
6.8.2 Indian Immunologicals Business Overview
6.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Indian Immunologicals Brucellosis Vaccines Product Portfolio
6.8.5 Indian Immunologicals Recent Developments
6.9 Qilu
6.9.1 Qilu Comapny Information
6.9.2 Qilu Business Overview
6.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qilu Brucellosis Vaccines Product Portfolio
6.9.5 Qilu Recent Developments
6.10 Tecnovax
6.10.1 Tecnovax Comapny Information
6.10.2 Tecnovax Business Overview
6.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tecnovax Brucellosis Vaccines Product Portfolio
6.10.5 Tecnovax Recent Developments
6.11 Hester Biosciences
6.11.1 Hester Biosciences Comapny Information
6.11.2 Hester Biosciences Business Overview
6.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hester Biosciences Brucellosis Vaccines Product Portfolio
6.11.5 Hester Biosciences Recent Developments
6.12 Zoetis
6.12.1 Zoetis Comapny Information
6.12.2 Zoetis Business Overview
6.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zoetis Brucellosis Vaccines Product Portfolio
6.12.5 Zoetis Recent Developments
6.13 Onderstepoort Biological
6.13.1 Onderstepoort Biological Comapny Information
6.13.2 Onderstepoort Biological Business Overview
6.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Onderstepoort Biological Brucellosis Vaccines Product Portfolio
6.13.5 Onderstepoort Biological Recent Developments
6.14 Instituto Rosenbusch
6.14.1 Instituto Rosenbusch Comapny Information
6.14.2 Instituto Rosenbusch Business Overview
6.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio
6.14.5 Instituto Rosenbusch Recent Developments
6.15 Ceva Sante Animale
6.15.1 Ceva Sante Animale Comapny Information
6.15.2 Ceva Sante Animale Business Overview
6.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Ceva Sante Animale Brucellosis Vaccines Product Portfolio
6.15.5 Ceva Sante Animale Recent Developments
6.16 Calier & Biologicos Laverlam
6.16.1 Calier & Biologicos Laverlam Comapny Information
6.16.2 Calier & Biologicos Laverlam Business Overview
6.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio
6.16.5 Calier & Biologicos Laverlam Recent Developments
6.17 Biovet
6.17.1 Biovet Comapny Information
6.17.2 Biovet Business Overview
6.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Biovet Brucellosis Vaccines Product Portfolio
6.17.5 Biovet Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Brucellosis Vaccines Sales by Country
7.1.1 North America Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Brucellosis Vaccines Sales by Country (2019-2024)
7.1.3 North America Brucellosis Vaccines Sales Forecast by Country (2025-2030)
7.2 North America Brucellosis Vaccines Market Size by Country
7.2.1 North America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Brucellosis Vaccines Market Size by Country (2019-2024)
7.2.3 North America Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Brucellosis Vaccines Sales by Country
8.1.1 Europe Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Brucellosis Vaccines Sales by Country (2019-2024)
8.1.3 Europe Brucellosis Vaccines Sales Forecast by Country (2025-2030)
8.2 Europe Brucellosis Vaccines Market Size by Country
8.2.1 Europe Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Brucellosis Vaccines Market Size by Country (2019-2024)
8.2.3 Europe Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Brucellosis Vaccines Sales by Country
9.1.1 Asia-Pacific Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Brucellosis Vaccines Sales by Country (2019-2024)
9.1.3 Asia-Pacific Brucellosis Vaccines Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Brucellosis Vaccines Market Size by Country
9.2.1 Asia-Pacific Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Brucellosis Vaccines Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Brucellosis Vaccines Sales by Country
10.1.1 Latin America Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Brucellosis Vaccines Sales by Country (2019-2024)
10.1.3 Latin America Brucellosis Vaccines Sales Forecast by Country (2025-2030)
10.2 Latin America Brucellosis Vaccines Market Size by Country
10.2.1 Latin America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Brucellosis Vaccines Market Size by Country (2019-2024)
10.2.3 Latin America Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Brucellosis Vaccines Sales by Country
11.1.1 Middle East and Africa Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Brucellosis Vaccines Sales by Country (2019-2024)
11.1.3 Middle East and Africa Brucellosis Vaccines Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Brucellosis Vaccines Market Size by Country
11.2.1 Middle East and Africa Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Brucellosis Vaccines Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Brucellosis Vaccines Value Chain Analysis
12.1.1 Brucellosis Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Brucellosis Vaccines Production Mode & Process
12.2 Brucellosis Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Brucellosis Vaccines Distributors
12.2.3 Brucellosis Vaccines Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Brucellosis Vaccines Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Brucellosis Vaccines Sales Estimates and Forecasts (2019-2030)
1.3 Brucellosis Vaccines Market by Type
1.3.1 S19 Vaccine
1.3.2 RB51 Vaccine Strain
1.4 Global Brucellosis Vaccines Market Size by Type
1.4.1 Global Brucellosis Vaccines Market Size Overview by Type (2019-2030)
1.4.2 Global Brucellosis Vaccines Historic Market Size Review by Type (2019-2024)
1.4.3 Global Brucellosis Vaccines Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
1.5.2 Europe Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Brucellosis Vaccines Industry Trends
2.2 Brucellosis Vaccines Industry Drivers
2.3 Brucellosis Vaccines Industry Opportunities and Challenges
2.4 Brucellosis Vaccines Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Brucellosis Vaccines Revenue (2019-2024)
3.2 Global Top Players by Brucellosis Vaccines Sales (2019-2024)
3.3 Global Top Players by Brucellosis Vaccines Price (2019-2024)
3.4 Global Brucellosis Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Brucellosis Vaccines Key Company Manufacturing Sites & Headquarters
3.6 Global Brucellosis Vaccines Company, Product Type & Application
3.7 Global Brucellosis Vaccines Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Brucellosis Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Brucellosis Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Brucellosis Vaccines Tier 1, Tier 2, and Tier
4 BRUCELLOSIS VACCINES REGIONAL STATUS AND OUTLOOK
4.1 Global Brucellosis Vaccines Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Brucellosis Vaccines Historic Market Size by Region
4.2.1 Global Brucellosis Vaccines Sales in Volume by Region (2019-2024)
4.2.2 Global Brucellosis Vaccines Sales in Value by Region (2019-2024)
4.2.3 Global Brucellosis Vaccines Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Brucellosis Vaccines Forecasted Market Size by Region
4.3.1 Global Brucellosis Vaccines Sales in Volume by Region (2025-2030)
4.3.2 Global Brucellosis Vaccines Sales in Value by Region (2025-2030)
4.3.3 Global Brucellosis Vaccines Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 BRUCELLOSIS VACCINES BY APPLICATION
5.1 Brucellosis Vaccines Market by Application
5.1.1 Cattle
5.1.2 Sheep
5.1.3 Others
5.2 Global Brucellosis Vaccines Market Size by Application
5.2.1 Global Brucellosis Vaccines Market Size Overview by Application (2019-2030)
5.2.2 Global Brucellosis Vaccines Historic Market Size Review by Application (2019-2024)
5.2.3 Global Brucellosis Vaccines Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
5.3.2 Europe Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Jinyu
6.1.1 Jinyu Comapny Information
6.1.2 Jinyu Business Overview
6.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jinyu Brucellosis Vaccines Product Portfolio
6.1.5 Jinyu Recent Developments
6.2 Colorado Serum
6.2.1 Colorado Serum Comapny Information
6.2.2 Colorado Serum Business Overview
6.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Colorado Serum Brucellosis Vaccines Product Portfolio
6.2.5 Colorado Serum Recent Developments
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Comapny Information
6.3.2 Boehringer Ingelheim Business Overview
6.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments
6.4 Biogenesis-Bago
6.4.1 Biogenesis-Bago Comapny Information
6.4.2 Biogenesis-Bago Business Overview
6.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biogenesis-Bago Brucellosis Vaccines Product Portfolio
6.4.5 Biogenesis-Bago Recent Developments
6.5 Vetal Company
6.5.1 Vetal Company Comapny Information
6.5.2 Vetal Company Business Overview
6.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vetal Company Brucellosis Vaccines Product Portfolio
6.5.5 Vetal Company Recent Developments
6.6 CZ Veterinaria
6.6.1 CZ Veterinaria Comapny Information
6.6.2 CZ Veterinaria Business Overview
6.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CZ Veterinaria Brucellosis Vaccines Product Portfolio
6.6.5 CZ Veterinaria Recent Developments
6.7 SYVA Laboratorios
6.7.1 SYVA Laboratorios Comapny Information
6.7.2 SYVA Laboratorios Business Overview
6.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 SYVA Laboratorios Brucellosis Vaccines Product Portfolio
6.7.5 SYVA Laboratorios Recent Developments
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Comapny Information
6.8.2 Indian Immunologicals Business Overview
6.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Indian Immunologicals Brucellosis Vaccines Product Portfolio
6.8.5 Indian Immunologicals Recent Developments
6.9 Qilu
6.9.1 Qilu Comapny Information
6.9.2 Qilu Business Overview
6.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qilu Brucellosis Vaccines Product Portfolio
6.9.5 Qilu Recent Developments
6.10 Tecnovax
6.10.1 Tecnovax Comapny Information
6.10.2 Tecnovax Business Overview
6.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tecnovax Brucellosis Vaccines Product Portfolio
6.10.5 Tecnovax Recent Developments
6.11 Hester Biosciences
6.11.1 Hester Biosciences Comapny Information
6.11.2 Hester Biosciences Business Overview
6.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hester Biosciences Brucellosis Vaccines Product Portfolio
6.11.5 Hester Biosciences Recent Developments
6.12 Zoetis
6.12.1 Zoetis Comapny Information
6.12.2 Zoetis Business Overview
6.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zoetis Brucellosis Vaccines Product Portfolio
6.12.5 Zoetis Recent Developments
6.13 Onderstepoort Biological
6.13.1 Onderstepoort Biological Comapny Information
6.13.2 Onderstepoort Biological Business Overview
6.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Onderstepoort Biological Brucellosis Vaccines Product Portfolio
6.13.5 Onderstepoort Biological Recent Developments
6.14 Instituto Rosenbusch
6.14.1 Instituto Rosenbusch Comapny Information
6.14.2 Instituto Rosenbusch Business Overview
6.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio
6.14.5 Instituto Rosenbusch Recent Developments
6.15 Ceva Sante Animale
6.15.1 Ceva Sante Animale Comapny Information
6.15.2 Ceva Sante Animale Business Overview
6.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Ceva Sante Animale Brucellosis Vaccines Product Portfolio
6.15.5 Ceva Sante Animale Recent Developments
6.16 Calier & Biologicos Laverlam
6.16.1 Calier & Biologicos Laverlam Comapny Information
6.16.2 Calier & Biologicos Laverlam Business Overview
6.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio
6.16.5 Calier & Biologicos Laverlam Recent Developments
6.17 Biovet
6.17.1 Biovet Comapny Information
6.17.2 Biovet Business Overview
6.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Biovet Brucellosis Vaccines Product Portfolio
6.17.5 Biovet Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Brucellosis Vaccines Sales by Country
7.1.1 North America Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Brucellosis Vaccines Sales by Country (2019-2024)
7.1.3 North America Brucellosis Vaccines Sales Forecast by Country (2025-2030)
7.2 North America Brucellosis Vaccines Market Size by Country
7.2.1 North America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Brucellosis Vaccines Market Size by Country (2019-2024)
7.2.3 North America Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Brucellosis Vaccines Sales by Country
8.1.1 Europe Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Brucellosis Vaccines Sales by Country (2019-2024)
8.1.3 Europe Brucellosis Vaccines Sales Forecast by Country (2025-2030)
8.2 Europe Brucellosis Vaccines Market Size by Country
8.2.1 Europe Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Brucellosis Vaccines Market Size by Country (2019-2024)
8.2.3 Europe Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Brucellosis Vaccines Sales by Country
9.1.1 Asia-Pacific Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Brucellosis Vaccines Sales by Country (2019-2024)
9.1.3 Asia-Pacific Brucellosis Vaccines Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Brucellosis Vaccines Market Size by Country
9.2.1 Asia-Pacific Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Brucellosis Vaccines Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Brucellosis Vaccines Sales by Country
10.1.1 Latin America Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Brucellosis Vaccines Sales by Country (2019-2024)
10.1.3 Latin America Brucellosis Vaccines Sales Forecast by Country (2025-2030)
10.2 Latin America Brucellosis Vaccines Market Size by Country
10.2.1 Latin America Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Brucellosis Vaccines Market Size by Country (2019-2024)
10.2.3 Latin America Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Brucellosis Vaccines Sales by Country
11.1.1 Middle East and Africa Brucellosis Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Brucellosis Vaccines Sales by Country (2019-2024)
11.1.3 Middle East and Africa Brucellosis Vaccines Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Brucellosis Vaccines Market Size by Country
11.2.1 Middle East and Africa Brucellosis Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Brucellosis Vaccines Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Brucellosis Vaccines Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Brucellosis Vaccines Value Chain Analysis
12.1.1 Brucellosis Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Brucellosis Vaccines Production Mode & Process
12.2 Brucellosis Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Brucellosis Vaccines Distributors
12.2.3 Brucellosis Vaccines Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
